Overview
Elisna Syahruddin practices in Jakarta, Indonesia. Syahruddin is rated as an Advanced expert by MediFind in the treatment of Thymic Epithelial Tumor. Their top areas of expertise are Mediastinal Tumor, Lung Cancer, EGFR Positive Lung Cancer, and Thymic Epithelial Tumor.
Their clinical research consists of co-authoring 27 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Thymic Epithelial Tumor.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- EGFR Positive Lung CancerSyahruddin isAdvanced. Learn about EGFR Positive Lung Cancer.
- Lung CancerSyahruddin isAdvanced. Learn about Lung Cancer.
- Mediastinal TumorSyahruddin isAdvanced. Learn about Mediastinal Tumor.
- Thymic Epithelial TumorSyahruddin isAdvanced. Learn about Thymic Epithelial Tumor.
- Experienced
- Adenoid Cystic CarcinomaSyahruddin isExperienced. Learn about Adenoid Cystic Carcinoma.
- Adult Soft Tissue SarcomaSyahruddin isExperienced. Learn about Adult Soft Tissue Sarcoma.
- COVID-19Syahruddin isExperienced. Learn about COVID-19.
- Lung AdenocarcinomaSyahruddin isExperienced. Learn about Lung Adenocarcinoma.
- Non-Small Cell Lung Cancer (NSCLC)Syahruddin isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- ParonychiaSyahruddin isExperienced. Learn about Paronychia.